Drawing for SIGNACOLOR

USPTO serial 99617553

SIGNACOLOR

Reviewed by CopyMark Law Group

Status 773
Filing date
Status date
Registration date
—
Examiner
GULIANO, ROBERT N
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SIGNACOLOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tricia L. Schulz

Tricia L. Schulz Foley & Lardner LLP150 E. Gilman St., Suite 5000Madison, WI 53703United States

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic preparations for medical purposes; Diagnostic reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, detecting cancer; Diagnostic kits comprising diagnostic agents, preparations and substances for medical useACTIVE—
010Medical diagnostic apparatus for detecting cancer excluding medical imaging apparatus; Medical diagnostic apparatus for testing for cancer excluding medical imaging apparatus; Blood testing apparatus, namely, blood collecting tubesACTIVE—
035Business consulting services in the field of healthcare; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposesACTIVE—
042Providing medical and scientific research information; Medical and scientific research in the field of genetic testing; Genetic testing for scientific research purposes; Providing a website featuring educational information in the field of clinical research; Providing information about medical research in the field of genetic testing and oncology; Software as a service (SAAS) services featuring software for collecting, verifying, storing, analyzing, and transmitting information and reports concerning genetics, genetic mutations, genetic test results, diagnoses and treatmentsACTIVE—
044Genetic testing for medical purposes; Genetic counseling; Medical laboratory analysis services relating to the treatment of persons; Providing information about genetic testing for medical purposes; Providing health information in the field of genetic testing and oncology; Genetic testing for cancer risk for medical purposes; Medical analysis services for the diagnosis of cancer; Medical analysis for the diagnosis and treatment of persons; Providing information in the field of the diagnosis and treatment of cancer via a website; Providing a web site featuring medical information; Providing a website featuring information in the field of the diagnosis and treatment of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 8, 2026ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Aug 6, 2026CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Aug 6, 2026APETASSIGNED TO PETITION STAFF—
Jul 8, 2026ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jun 30, 2026EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Jun 30, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 30, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 24, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 1, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 26, 2026DOCKASSIGNED TO EXAMINER—
May 18, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 27, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 27, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance